Sanovel İlaç

Sanovel İlaç is a prominent pharmaceutical company that was founded in 1983 by Pharmacist Erol Toksöz. With an annual production capacity of 227 million units and EU GMP (Good Manufacturing Practices) certification, the company has set its sights on becoming a global pharmaceutical player. Sanovel operates with a steadfast commitment to robust R&D, boasting an extensive product portfolio that includes over 60 brands and 180 products. The company also prides itself on its team of over 1,600 individuals, dedicated to promoting long and healthy lives. Standing out as the first and only Turkish pharmaceutical company approved by the American Food and Drug Administration (FDA), Sanovel achieved this feat without encountering any major or critical observations. With a strong focus on R&D, patents, and intellectual property rights, the company leads the charge in offering equivalent products across a wide range of treatment areas. The Sanovel R&D Center & Production Campus in İstanbul Silivri represents a key milestone in the company's journey, boasting a production site with a capacity of 227 million units per year. Sanovel has consistently demonstrated its leadership position in intellectual property competence within the industry, earning the title of patent champion in the Turkish pharmaceutical sector. Driven by a resolute vision, Sanovel places strong emphasis on sustainability and aims to create a balanced and valuable life for its dedicated workforce. The company is committed to contributing to the Turkish pharmaceutical industry and the national economy with the overarching goal of promoting lifelong health worldwide.